首页 > 最新文献

Frontiers in Neuroscience最新文献

英文 中文
Editorial: Physical exercise and brain health: functional mediators and therapeutic targets focusing on neuroendocrinology 社论:体育锻炼与大脑健康:以神经内分泌学为重点的功能介质和治疗目标
Pub Date : 2024-04-25 DOI: 10.3389/fnins.2024.1415752
Weina Liu, Laura Piccardi, Howe Liu, Li Zhang, Chengyi Liu, Jie Xia
{"title":"Editorial: Physical exercise and brain health: functional mediators and therapeutic targets focusing on neuroendocrinology","authors":"Weina Liu, Laura Piccardi, Howe Liu, Li Zhang, Chengyi Liu, Jie Xia","doi":"10.3389/fnins.2024.1415752","DOIUrl":"https://doi.org/10.3389/fnins.2024.1415752","url":null,"abstract":"","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"5 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140654344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis 治疗重度抑郁障碍的舒拉诺龙:系统综述和荟萃分析
Pub Date : 2024-04-25 DOI: 10.3389/fnins.2024.1361692
Abdullah Ahmad, Abdul Rafeh Awan, Natasha Nadeem, Aamir Shahid Javed, Mobeen Farooqi, Muhammed Daniyal, Hassan Mumtaz
Current treatment modalities for Major Depressive Disorder have variable efficacies and a variety of side effects. To amend this, many trials for short term, well tolerated monotherapies are underway. One such option is Zuranolone (SAGE-217), which is a recent FDA approved antidepressant for Post Partum depression (PPD) and is undergoing clinical trials for PPD, major depressive disorder (MDD) and essential tremors (ET).Pool currently available data that compare Zuranolone to Placebo for the treatment of Major Depressive Disorder and evaluate its efficacy and safety profile.We retrieved data from PUBMED and SCOPUS from inception to July 2023. We included articles comparing Zuranolone or SAGE 217 with placebo in patients suffering from Major Depressive Disorder. Review Manager 5.4 was used to analyze the outcomes including changes in the Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A) and Montgomery–Åsberg Depression Rating Scale (MADRS) scores from baseline as well as any treatment emergent adverse events (TEAEs) and severe adverse events.Our review analyzed 4 trials and the data of 1,357 patients. Patients treated with Zuranolone indicated a statistically significant effect in the change from baseline in HAM-D score (p = 0.0009; MD [95% CI]: −2.03 [−3.23, −0.84]) as well as in MADRS score (p = 0.02; MD [95% CI]: −2.30[−4.31, −0.30]) and HAM-A score (p = 0.03; MD [95% CI]: −1.41[−2.70, −0.11]) on 15th day when compared to the Placebo group. Zuranolone was also significantly associated with a higher response rate (p = 0.0008; OR [95% CI]: 1.63[1.14, 2.35]) and higher remission rate (p = 0.03; OR [95% CI]: 1.65[1.05, 2.59]) when compared with the placebo. As for safety, Zuranolone was significantly associated with 1 or more TEAE (p = 0.006; RR [95% CI]: 1.14[1.04, 1.24]) but an insignificant association with side effects that lead to drug discontinuation (p = 0.70; RR [95% CI]: 1.18[0.51, 2.76]) and serious adverse events (p = 0.48; RR [95% CI]: 1.46 [0.52, 4.10]) when compared with placebo.Zuranolone is an effective and safe drug for short course major depressive disorder monotherapy. It shows results in 14 days (compared to 2–4 weeks that SSRI’s take) and has anti-anxiolytic effects as well. However, only 4 trials have been used for the analysis and the sample size was small. The trials reviewed also cannot determine the long-term effects of the drug. More trials are needed to determine long term effects.
目前治疗重度抑郁症的方法疗效不一,副作用也多种多样。为了改变这种状况,许多短期、耐受性良好的单一疗法试验正在进行中。Zuranolone (SAGE-217)就是其中一种选择,它是最近获得 FDA 批准用于治疗产后抑郁症(PPD)的抗抑郁药,目前正在进行治疗 PPD、重度抑郁障碍(MDD)和本质性震颤(ET)的临床试验。我们从 PUBMED 和 SCOPUS 中检索了从 2023 年 7 月开始的数据。我们纳入了对重度抑郁障碍患者进行祖诺龙或 SAGE 217 与安慰剂比较的文章。我们使用Review Manager 5.4分析了结果,包括汉密尔顿抑郁评定量表(HAM-D)、汉密尔顿焦虑评定量表(HAM-A)和蒙哥马利-阿斯伯格抑郁评定量表(MADRS)评分与基线相比的变化,以及任何治疗突发不良事件(TEAEs)和严重不良事件。与安慰剂组相比,接受祖诺龙治疗的患者在第15天的HAM-D评分(p = 0.0009; MD [95% CI]: -2.03 [-3.23, -0.84])、MADRS评分(p = 0.02; MD [95% CI]: -2.30[-4.31, -0.30])和HAM-A评分(p = 0.03; MD [95% CI]: -1.41[-2.70, -0.11])与基线相比的变化具有统计学意义。与安慰剂组相比,Zuranolone 还与更高的应答率(p = 0.0008;OR [95%CI]:1.63[1.14, 2.35])和更高的缓解率(p = 0.03;OR [95%CI]:1.65[1.05, 2.59])显著相关。在安全性方面,祖拉诺龙与 1 种或 1 种以上 TEAE 显著相关(p = 0.006;RR [95% CI]:1.14[1.04, 1.24]),但与导致停药的副作用关系不大(p = 0.与安慰剂相比,Zuranolone 是一种有效且安全的短期重度抑郁障碍单药治疗药物。苏拉诺龙是一种有效、安全的短期重度抑郁障碍单药治疗药物,14 天即可见效(而 SSRI 需要 2-4 周),并具有抗焦虑作用。不过,只有 4 项试验被用于分析,而且样本量较小。所审查的试验也无法确定该药物的长期效果。需要更多的试验来确定其长期效果。
{"title":"Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis","authors":"Abdullah Ahmad, Abdul Rafeh Awan, Natasha Nadeem, Aamir Shahid Javed, Mobeen Farooqi, Muhammed Daniyal, Hassan Mumtaz","doi":"10.3389/fnins.2024.1361692","DOIUrl":"https://doi.org/10.3389/fnins.2024.1361692","url":null,"abstract":"Current treatment modalities for Major Depressive Disorder have variable efficacies and a variety of side effects. To amend this, many trials for short term, well tolerated monotherapies are underway. One such option is Zuranolone (SAGE-217), which is a recent FDA approved antidepressant for Post Partum depression (PPD) and is undergoing clinical trials for PPD, major depressive disorder (MDD) and essential tremors (ET).Pool currently available data that compare Zuranolone to Placebo for the treatment of Major Depressive Disorder and evaluate its efficacy and safety profile.We retrieved data from PUBMED and SCOPUS from inception to July 2023. We included articles comparing Zuranolone or SAGE 217 with placebo in patients suffering from Major Depressive Disorder. Review Manager 5.4 was used to analyze the outcomes including changes in the Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A) and Montgomery–Åsberg Depression Rating Scale (MADRS) scores from baseline as well as any treatment emergent adverse events (TEAEs) and severe adverse events.Our review analyzed 4 trials and the data of 1,357 patients. Patients treated with Zuranolone indicated a statistically significant effect in the change from baseline in HAM-D score (p = 0.0009; MD [95% CI]: −2.03 [−3.23, −0.84]) as well as in MADRS score (p = 0.02; MD [95% CI]: −2.30[−4.31, −0.30]) and HAM-A score (p = 0.03; MD [95% CI]: −1.41[−2.70, −0.11]) on 15th day when compared to the Placebo group. Zuranolone was also significantly associated with a higher response rate (p = 0.0008; OR [95% CI]: 1.63[1.14, 2.35]) and higher remission rate (p = 0.03; OR [95% CI]: 1.65[1.05, 2.59]) when compared with the placebo. As for safety, Zuranolone was significantly associated with 1 or more TEAE (p = 0.006; RR [95% CI]: 1.14[1.04, 1.24]) but an insignificant association with side effects that lead to drug discontinuation (p = 0.70; RR [95% CI]: 1.18[0.51, 2.76]) and serious adverse events (p = 0.48; RR [95% CI]: 1.46 [0.52, 4.10]) when compared with placebo.Zuranolone is an effective and safe drug for short course major depressive disorder monotherapy. It shows results in 14 days (compared to 2–4 weeks that SSRI’s take) and has anti-anxiolytic effects as well. However, only 4 trials have been used for the analysis and the sample size was small. The trials reviewed also cannot determine the long-term effects of the drug. More trials are needed to determine long term effects.","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"8 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140653311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perturbing cortical networks: in vivo electrophysiological consequences of pan-neuronal chemogenetic manipulations using deschloroclozapine 扰乱大脑皮层网络:使用去氯氮平进行泛神经元化学遗传学操作的体内电生理学后果
Pub Date : 2024-04-25 DOI: 10.3389/fnins.2024.1396978
Péter Kovács, Lauren N Beloate, Nanyin Zhang
Chemogenetic techniques, specifically the use of Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), have become invaluable tools in neuroscience research. Yet, the understanding of how Gq- and Gicoupled DREADDs alter local field potential (LFP) oscillations in vivo remains incomplete.This study investigates the in vivo electrophysiological effects of DREADD actuation by deschloroclozapine, on spontaneous firing rate and LFP oscillations recorded from the anterior cingulate cortex in lightly anesthetized male rats.Unexpectedly, in response to the administration of deschloroclozapine, we observed inhibitory effects with pan-neuronal hM3D(Gq) stimulation, and excitatory effects with pan-neuronal hM4D(Gi) stimulation in a significant portion of neurons. These results emphasize the need to account for indirect perturbation effects at the local neuronal network level in vivo, particularly when not all neurons express the chemogenetic receptors uniformly. In the current study, for instance, the majority of cells that were transduced with both hM3D(Gq) and hM4D(Gi) were GABAergic. Moreover, we found that panneuronal cortical chemogenetic modulation can profoundly alter oscillatory neuronal activity, presenting a potential research tool or therapeutic strategy in several neuropsychiatric models and diseases.These findings help to optimize the use of chemogenetic techniques in neuroscience research and open new possibilities for novel therapeutic strategies.
化学遗传学技术,特别是通过设计药物专门激活的设计受体(DREADDs)的使用,已成为神经科学研究的宝贵工具。本研究调查了去氯氯氮平(deschloroclozapine)激活 DREADD 对轻度麻醉雄性大鼠前扣带回皮层记录的自发发射率和 LFP 振荡的体内电生理效应。意想不到的是,在服用去氯氯氮平之后,我们在相当一部分神经元中观察到了泛神经元 hM3D(Gq)刺激的抑制作用和泛神经元 hM4D(Gi)刺激的兴奋作用。这些结果表明,需要考虑体内局部神经元网络水平的间接扰动效应,尤其是当并非所有神经元都一致表达化学基因受体时。例如,在目前的研究中,同时转导了 hM3D(Gq) 和 hM4D(Gi) 的细胞大多具有 GABA 能。此外,我们还发现,泛神经元皮层化学遗传调控能显著改变神经元的振荡活动,为多种神经精神模型和疾病提供了潜在的研究工具或治疗策略。这些发现有助于优化化学遗传技术在神经科学研究中的应用,并为新型治疗策略提供了新的可能性。
{"title":"Perturbing cortical networks: in vivo electrophysiological consequences of pan-neuronal chemogenetic manipulations using deschloroclozapine","authors":"Péter Kovács, Lauren N Beloate, Nanyin Zhang","doi":"10.3389/fnins.2024.1396978","DOIUrl":"https://doi.org/10.3389/fnins.2024.1396978","url":null,"abstract":"Chemogenetic techniques, specifically the use of Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), have become invaluable tools in neuroscience research. Yet, the understanding of how Gq- and Gicoupled DREADDs alter local field potential (LFP) oscillations in vivo remains incomplete.This study investigates the in vivo electrophysiological effects of DREADD actuation by deschloroclozapine, on spontaneous firing rate and LFP oscillations recorded from the anterior cingulate cortex in lightly anesthetized male rats.Unexpectedly, in response to the administration of deschloroclozapine, we observed inhibitory effects with pan-neuronal hM3D(Gq) stimulation, and excitatory effects with pan-neuronal hM4D(Gi) stimulation in a significant portion of neurons. These results emphasize the need to account for indirect perturbation effects at the local neuronal network level in vivo, particularly when not all neurons express the chemogenetic receptors uniformly. In the current study, for instance, the majority of cells that were transduced with both hM3D(Gq) and hM4D(Gi) were GABAergic. Moreover, we found that panneuronal cortical chemogenetic modulation can profoundly alter oscillatory neuronal activity, presenting a potential research tool or therapeutic strategy in several neuropsychiatric models and diseases.These findings help to optimize the use of chemogenetic techniques in neuroscience research and open new possibilities for novel therapeutic strategies.","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"84 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140655409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Promising therapeutic strategies for Alzheimer's disease: a focus on amyloid-β targeting 社论:阿尔茨海默病的前景看好的治疗策略:关注淀粉样蛋白-β靶向治疗
Pub Date : 2024-04-25 DOI: 10.3389/fnins.2024.1415641
A. Bigi, Ryan Limbocker, Cristina Cecchi
{"title":"Editorial: Promising therapeutic strategies for Alzheimer's disease: a focus on amyloid-β targeting","authors":"A. Bigi, Ryan Limbocker, Cristina Cecchi","doi":"10.3389/fnins.2024.1415641","DOIUrl":"https://doi.org/10.3389/fnins.2024.1415641","url":null,"abstract":"","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"3 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mobilizing endogenous neuroprotection: the mechanism of the protective effect of acupuncture on the brain after stroke 调动内源性神经保护功能:针灸对中风后大脑保护作用的机制
Pub Date : 2024-04-25 DOI: 10.3389/fnins.2024.1181670
Tian-cong Fu, Guan-ran Wang, Yu-xuan Li, Zhi-fang Xu, Can Wang, Run-chen Zhang, Qing-tao Ma, Ya-jing Ma, Yi Guo, Xiao-yu Dai, Yang Guo
Given its high morbidity, disability, and mortality rates, ischemic stroke (IS) is a severe disease posing a substantial public health threat. Although early thrombolytic therapy is effective in IS treatment, the limited time frame for its administration presents a formidable challenge. Upon occurrence, IS triggers an ischemic cascade response, inducing the brain to generate endogenous protective mechanisms against excitotoxicity and inflammation, among other pathological processes. Stroke patients often experience limited recovery stages. As a result, activating their innate self-protective capacity [endogenous brain protection (EBP)] is essential for neurological function recovery. Acupuncture has exhibited clinical efficacy in cerebral ischemic stroke (CIS) treatment by promoting the human body's self-preservation and “Zheng Qi” (a term in traditional Chinese medicine (TCM) describing positive capabilities such as self-immunity, self-recovery, and disease prevention). According to research, acupuncture can modulate astrocyte activity, decrease oxidative stress (OS), and protect neurons by inhibiting excitotoxicity, inflammation, and apoptosis via activating endogenous protective mechanisms within the brain. Furthermore, acupuncture was found to modulate microglia transformation, thereby reducing inflammation and autoimmune responses, as well as promoting blood flow restoration by regulating the vasculature or the blood–brain barrier (BBB). However, the precise mechanism underlying these processes remains unclear. Consequently, this review aims to shed light on the potential acupuncture-induced endogenous neuroprotective mechanisms by critically examining experimental evidence on the preventive and therapeutic effects exerted by acupuncture on CIS. This review offers a theoretical foundation for acupuncture-based stroke treatment.
缺血性脑卒中(IS)发病率高、致残率高、死亡率高,是一种严重的疾病,对公共健康构成了巨大威胁。虽然早期溶栓治疗对治疗缺血性中风很有效,但由于时间有限,给治疗带来了巨大挑战。脑卒中(IS)发生后会引发缺血级联反应,诱导大脑产生内源性保护机制,对抗兴奋毒性和炎症等病理过程。中风患者的恢复阶段往往有限。因此,激活他们与生俱来的自我保护能力[内源性脑保护(EBP)]对于神经功能的恢复至关重要。针灸通过促进人体的自我保护能力和 "正气"(传统中医对自我免疫、自我恢复和预防疾病等积极能力的描述),在脑缺血中风(CIS)治疗中显示出临床疗效。研究表明,针灸可以调节星形胶质细胞的活性,降低氧化应激(OS),并通过激活脑内的内源性保护机制,抑制兴奋毒性、炎症和细胞凋亡,从而保护神经元。此外,针灸还能调节小胶质细胞的转化,从而减轻炎症和自身免疫反应,并通过调节血管或血脑屏障(BBB)促进血流恢复。然而,这些过程的确切机制仍不清楚。因此,本综述旨在通过批判性研究针灸对 CIS 的预防和治疗作用的实验证据,阐明针灸诱导的潜在内源性神经保护机制。本综述为基于针灸的中风治疗提供了理论基础。
{"title":"Mobilizing endogenous neuroprotection: the mechanism of the protective effect of acupuncture on the brain after stroke","authors":"Tian-cong Fu, Guan-ran Wang, Yu-xuan Li, Zhi-fang Xu, Can Wang, Run-chen Zhang, Qing-tao Ma, Ya-jing Ma, Yi Guo, Xiao-yu Dai, Yang Guo","doi":"10.3389/fnins.2024.1181670","DOIUrl":"https://doi.org/10.3389/fnins.2024.1181670","url":null,"abstract":"Given its high morbidity, disability, and mortality rates, ischemic stroke (IS) is a severe disease posing a substantial public health threat. Although early thrombolytic therapy is effective in IS treatment, the limited time frame for its administration presents a formidable challenge. Upon occurrence, IS triggers an ischemic cascade response, inducing the brain to generate endogenous protective mechanisms against excitotoxicity and inflammation, among other pathological processes. Stroke patients often experience limited recovery stages. As a result, activating their innate self-protective capacity [endogenous brain protection (EBP)] is essential for neurological function recovery. Acupuncture has exhibited clinical efficacy in cerebral ischemic stroke (CIS) treatment by promoting the human body's self-preservation and “Zheng Qi” (a term in traditional Chinese medicine (TCM) describing positive capabilities such as self-immunity, self-recovery, and disease prevention). According to research, acupuncture can modulate astrocyte activity, decrease oxidative stress (OS), and protect neurons by inhibiting excitotoxicity, inflammation, and apoptosis via activating endogenous protective mechanisms within the brain. Furthermore, acupuncture was found to modulate microglia transformation, thereby reducing inflammation and autoimmune responses, as well as promoting blood flow restoration by regulating the vasculature or the blood–brain barrier (BBB). However, the precise mechanism underlying these processes remains unclear. Consequently, this review aims to shed light on the potential acupuncture-induced endogenous neuroprotective mechanisms by critically examining experimental evidence on the preventive and therapeutic effects exerted by acupuncture on CIS. This review offers a theoretical foundation for acupuncture-based stroke treatment.","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"60 24","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140655532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Pathway to recovery: understanding the plastic changes in neural circuits leading to recovery 社论:康复之路:了解神经回路中导致康复的可塑性变化
Pub Date : 2024-04-24 DOI: 10.3389/fnins.2024.1411938
Mesut Sahin, Sean K. Meehan, George C. McConnell
{"title":"Editorial: Pathway to recovery: understanding the plastic changes in neural circuits leading to recovery","authors":"Mesut Sahin, Sean K. Meehan, George C. McConnell","doi":"10.3389/fnins.2024.1411938","DOIUrl":"https://doi.org/10.3389/fnins.2024.1411938","url":null,"abstract":"","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"66 15","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140663819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain functional connectivity in hyperthyroid patients: systematic review 甲状腺功能亢进患者的大脑功能连接:系统性综述
Pub Date : 2024-04-24 DOI: 10.3389/fnins.2024.1383355
Ephrem Tesfaye, Mihret Getnet, Desalegn Anmut Bitew, D. Adugna, Lemlemu Maru
Functional connectivity (FC) is the correlation between brain regions’ activities, studied through neuroimaging techniques like fMRI. It helps researchers understand brain function, organization, and dysfunction. Hyperthyroidism, characterized by high serum levels of free thyroxin and suppressed thyroid stimulating hormone, can lead to mood disturbance, cognitive impairment, and psychiatric symptoms. Excessive thyroid hormone exposure can enhance neuronal death and decrease brain volume, affecting memory, attention, emotion, vision, and motor planning.We conducted thorough searches across Google Scholar, PubMed, Hinari, and Science Direct to locate pertinent articles containing original data investigating FC measures in individuals diagnosed with hyperthyroidism.The systematic review identified 762 articles, excluding duplicates and non-matching titles and abstracts. Four full-text articles were included in this review. In conclusion, a strong bilateral hippocampal connection in hyperthyroid individuals suggests a possible neurobiological influence on brain networks that may affect cognitive and emotional processing.PROSPERO, CRD42024516216.
功能连接(FC)是指大脑区域活动之间的相关性,通过 fMRI 等神经成像技术进行研究。它有助于研究人员了解大脑的功能、组织和功能障碍。甲状腺功能亢进症的特点是血清中游离甲状腺素水平高而促甲状腺激素受抑制,可导致情绪紊乱、认知障碍和精神症状。我们在 Google Scholar、PubMed、Hinari 和 Science Direct 等网站上进行了全面搜索,以找到包含原始数据的相关文章,这些数据调查了被诊断为甲状腺功能亢进症患者的 FC 测量。本综述收录了四篇全文文章。总之,甲状腺机能亢进症患者双侧海马体的联系很强,这表明可能存在对大脑网络的神经生物学影响,而大脑网络可能会影响认知和情绪处理。
{"title":"Brain functional connectivity in hyperthyroid patients: systematic review","authors":"Ephrem Tesfaye, Mihret Getnet, Desalegn Anmut Bitew, D. Adugna, Lemlemu Maru","doi":"10.3389/fnins.2024.1383355","DOIUrl":"https://doi.org/10.3389/fnins.2024.1383355","url":null,"abstract":"Functional connectivity (FC) is the correlation between brain regions’ activities, studied through neuroimaging techniques like fMRI. It helps researchers understand brain function, organization, and dysfunction. Hyperthyroidism, characterized by high serum levels of free thyroxin and suppressed thyroid stimulating hormone, can lead to mood disturbance, cognitive impairment, and psychiatric symptoms. Excessive thyroid hormone exposure can enhance neuronal death and decrease brain volume, affecting memory, attention, emotion, vision, and motor planning.We conducted thorough searches across Google Scholar, PubMed, Hinari, and Science Direct to locate pertinent articles containing original data investigating FC measures in individuals diagnosed with hyperthyroidism.The systematic review identified 762 articles, excluding duplicates and non-matching titles and abstracts. Four full-text articles were included in this review. In conclusion, a strong bilateral hippocampal connection in hyperthyroid individuals suggests a possible neurobiological influence on brain networks that may affect cognitive and emotional processing.PROSPERO, CRD42024516216.","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140660346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends and hotspots in acupuncture treatment of rat models of stroke: a bibliometric analysis from 2004 to 2023 针灸治疗中风大鼠模型的趋势和热点:2004-2023 年文献计量分析
Pub Date : 2024-04-24 DOI: 10.3389/fnins.2024.1383283
Song Li, Zhilin Huang, Tao Zhu, Anhong Dai, Xu Chen, Xiaolin Yang, Li Zhou, YiZhou Chen, Jing Shi
Acupuncture is a widely used clinical treatment method, and studies have confirmed its therapeutic effects on stroke patients. It can also reduce the burden on patients and society. Acupuncture treatment is a complementary and preventive treatment for stroke. However, there has yet to be a visual bibliometric analysis of the field of acupuncture for stroke rat models. This study explores future trends, research hotspots, and frontiers in acupuncture for stroke rat models over the past 20 years through investigation and visualization.We collected literature data on acupuncture treatment of stroke in rats from the Web of Science Core Collection (WOSCC) database from January 1, 2004, to December 31, 2023. Import into CiteSpace (version 6.2.R4) and RStudio for analysis by author, country/region, affiliation, annual publication, keywords, and journal visualization.A total of 379 articles were retrieved, including articles from 16 countries, 258 research institutions, and 123 academic journals. The countries and institutions with the most publications were the People’s Republic of China (338) and the Fujian University of Traditional Chinese Medicine (43). Tao, Jing had the highest number of co-citations (144). The keywords and co-citation clustering show the main research directions in the field, including “artery occlusion,” “neural regeneration,” “stimulation,” “rapid tolerance,” “receptor,” “signaling pathway,” “apoptosis,” “oxidative stress,” “inflammatory response,” “endogenous neurogenesis,” “tolerance of local cerebral ischemic tissues,” “proliferation of reactive astrocytes” and “neuroprotective effect.” The intervention combines classical acupuncture treatment and modern technology (electricity) with electroacupuncture as a new intervention modality.This study demonstrates the increasing research on acupuncture for treating stroke in rat models. The country/region with the most publications is the People’s Republic of China. However, international cooperation still needs to be improved, and future researchers must strengthen international cooperation. In addition, in future studies, researchers should improve the overall quality of research results in this area and enhance research protocols.
针灸是一种广泛应用于临床的治疗方法,研究证实其对中风患者有一定的治疗效果。它还可以减轻患者和社会的负担。针灸治疗是中风的辅助和预防治疗方法。然而,针灸治疗中风大鼠模型领域尚未有直观的文献计量分析。本研究通过调查和可视化的方式探讨了过去20年针灸治疗中风大鼠模型的未来趋势、研究热点和前沿领域。我们从科学网核心库(WOSCC)数据库中收集了2004年1月1日至2023年12月31日有关针灸治疗中风大鼠的文献数据。导入 CiteSpace(6.2.R4 版)和 RStudio,按作者、国家/地区、所属单位、年发表量、关键词和期刊可视化进行分析。共检索到 379 篇文章,包括来自 16 个国家、258 个研究机构和 123 种学术期刊的文章。发表文章最多的国家和机构是中华人民共和国(338 篇)和福建中医药大学(43 篇)。陶静的共被引次数最多(144 次)。关键词和共引文聚类显示了该领域的主要研究方向,包括 "动脉闭塞"、"神经再生"、"刺激"、"快速耐受"、"受体"、"信号通路"、"细胞凋亡"、"氧化应激"、"炎症反应"、"内源性神经发生"、"局部脑缺血组织耐受"、"反应性星形胶质细胞增殖 "和 "神经保护作用"。这项研究表明,针灸治疗中风大鼠模型的研究日益增多。发表论文最多的国家/地区是中华人民共和国。然而,国际合作仍有待提高,未来的研究人员必须加强国际合作。此外,在今后的研究中,研究人员应提高该领域研究成果的整体质量,并改进研究方案。
{"title":"Trends and hotspots in acupuncture treatment of rat models of stroke: a bibliometric analysis from 2004 to 2023","authors":"Song Li, Zhilin Huang, Tao Zhu, Anhong Dai, Xu Chen, Xiaolin Yang, Li Zhou, YiZhou Chen, Jing Shi","doi":"10.3389/fnins.2024.1383283","DOIUrl":"https://doi.org/10.3389/fnins.2024.1383283","url":null,"abstract":"Acupuncture is a widely used clinical treatment method, and studies have confirmed its therapeutic effects on stroke patients. It can also reduce the burden on patients and society. Acupuncture treatment is a complementary and preventive treatment for stroke. However, there has yet to be a visual bibliometric analysis of the field of acupuncture for stroke rat models. This study explores future trends, research hotspots, and frontiers in acupuncture for stroke rat models over the past 20 years through investigation and visualization.We collected literature data on acupuncture treatment of stroke in rats from the Web of Science Core Collection (WOSCC) database from January 1, 2004, to December 31, 2023. Import into CiteSpace (version 6.2.R4) and RStudio for analysis by author, country/region, affiliation, annual publication, keywords, and journal visualization.A total of 379 articles were retrieved, including articles from 16 countries, 258 research institutions, and 123 academic journals. The countries and institutions with the most publications were the People’s Republic of China (338) and the Fujian University of Traditional Chinese Medicine (43). Tao, Jing had the highest number of co-citations (144). The keywords and co-citation clustering show the main research directions in the field, including “artery occlusion,” “neural regeneration,” “stimulation,” “rapid tolerance,” “receptor,” “signaling pathway,” “apoptosis,” “oxidative stress,” “inflammatory response,” “endogenous neurogenesis,” “tolerance of local cerebral ischemic tissues,” “proliferation of reactive astrocytes” and “neuroprotective effect.” The intervention combines classical acupuncture treatment and modern technology (electricity) with electroacupuncture as a new intervention modality.This study demonstrates the increasing research on acupuncture for treating stroke in rat models. The country/region with the most publications is the People’s Republic of China. However, international cooperation still needs to be improved, and future researchers must strengthen international cooperation. In addition, in future studies, researchers should improve the overall quality of research results in this area and enhance research protocols.","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"43 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140662907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validating the reproducibility of a low-cost single-channel fNIRS device across hierarchical cognitive tasks 验证低成本单通道 fNIRS 设备在不同层次认知任务中的可重复性
Pub Date : 2024-04-24 DOI: 10.3389/fnins.2024.1351341
Shiyang Xu, XingLing Zeng, Fuxian Yin, Chao Zhang
This study evaluates a low-cost, single-channel fNIRS device in cognitive neuroscience, aiming to overcome the financial barriers of commercial systems by testing its efficacy in tasks of varying complexity. Twenty-six participants engaged in motor control (finger-tapping), working memory (n-back), and creativity (AUT) tasks while their prefrontal cortex activity was monitored using the device, with behavioral and cerebral blood flow changes recorded. Results showed the device’s capability to detect significant blood flow variations across different tasks, thereby supporting its use in cognitive research. The study confirms the potential of single-channel fNIRS as a cost-effective tool for diverse cognitive assessments, from simple motor actions to complex creative thinking.
本研究评估了认知神经科学中的低成本单通道 fNIRS 设备,旨在通过测试其在不同复杂任务中的功效,克服商业系统的经济障碍。26 名参与者参与了运动控制(敲击手指)、工作记忆(n-back)和创造力(AUT)任务,同时使用该设备监测了他们的前额叶皮层活动,并记录了行为和脑血流变化。结果表明,该设备能够检测不同任务中的显著血流变化,从而支持其在认知研究中的应用。这项研究证实了单通道 fNIRS 作为一种具有成本效益的工具的潜力,可用于从简单的运动动作到复杂的创造性思维等各种认知评估。
{"title":"Validating the reproducibility of a low-cost single-channel fNIRS device across hierarchical cognitive tasks","authors":"Shiyang Xu, XingLing Zeng, Fuxian Yin, Chao Zhang","doi":"10.3389/fnins.2024.1351341","DOIUrl":"https://doi.org/10.3389/fnins.2024.1351341","url":null,"abstract":"This study evaluates a low-cost, single-channel fNIRS device in cognitive neuroscience, aiming to overcome the financial barriers of commercial systems by testing its efficacy in tasks of varying complexity. Twenty-six participants engaged in motor control (finger-tapping), working memory (n-back), and creativity (AUT) tasks while their prefrontal cortex activity was monitored using the device, with behavioral and cerebral blood flow changes recorded. Results showed the device’s capability to detect significant blood flow variations across different tasks, thereby supporting its use in cognitive research. The study confirms the potential of single-channel fNIRS as a cost-effective tool for diverse cognitive assessments, from simple motor actions to complex creative thinking.","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"27 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140663615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual cortex anodal transcranial direct current stimulation does not alter reading performance for Chinese presented character-by-character to normal peripheral vision in older adults 视觉皮层阳极经颅直流电刺激不会改变老年人在正常周边视力下逐字阅读中文的能力
Pub Date : 2024-04-24 DOI: 10.3389/fnins.2024.1341307
Anqi Lyu, Andrew E. Silva, Benjamin Thompson, Larry Abel, A. M. Y. Cheong
Visual cortex anodal transcranial direct current stimulation (a-tDCS) has been shown to reduce crowding in normal peripheral vision and may improve the reading of English words in patients with macular degeneration. Given the different visual requirements of reading English words and Chinese characters, the effect of a-tDCS on peripheral reading performance in English might differ from Chinese. This study recruited 20 participants (59–73 years of age) with normal vision and tested the hypothesis that a-tDCS would improve the reading of Chinese characters presented at 10° eccentricity compared with sham stimulation. Chinese sentences of different print sizes and exposure durations were presented one character at a time, 10° below or to the left of fixation. The individual critical print size (CPS) – the smallest print size eliciting the maximum reading speed (MRS) – was determined. Reading accuracies for characters presented 0.2 logMAR smaller than the individually fitted CPS were measured at four time points: before, during, 5 min after, and 30 min after receiving active or sham visual cortex a-tDCS. Participants completed both the active and sham sessions in a random order following a double-blind, within-subject design. No effect of active a-tDCS on reading accuracy was observed, implying that a single session of a-tDCS did not improve Chinese character reading in normal peripheral vision. This may suggest that a-tDCS does not significantly reduce the crowding elicited within a single Chinese character. However, the effect of a-tDCS on between-character crowding is yet to be determined.
研究表明,视觉皮层阳极经颅直流电刺激(a-tDCS)可减少正常周边视力的拥挤,并可改善黄斑变性患者的英语单词阅读能力。鉴于阅读英文单词和汉字的视觉要求不同,a-tDCS 对英文外周阅读能力的影响可能与中文不同。本研究招募了 20 名视力正常的参与者(59-73 岁),测试了 a-tDCS 与假刺激相比能提高 10° 偏心率下汉字阅读能力的假设。不同印刷尺寸和曝光持续时间的中文句子每次显示一个汉字,位置在固定点左下方或左上方 10°。研究人员确定了每个人的临界印刷尺寸(CPS),即能引起最大阅读速度(MRS)的最小印刷尺寸。在四个时间点测量了比单独拟合的 CPS 小 0.2 logMAR 的字符的阅读准确率:接受主动或假性视觉皮层 a-tDCS 治疗前、治疗期间、治疗后 5 分钟和治疗后 30 分钟。按照双盲、受试者内设计,受试者以随机顺序完成主动和假治疗。结果表明,主动a-tDCS对阅读准确性没有影响,这意味着单次a-tDCS治疗并不能提高正常周边视力下的汉字阅读能力。这可能表明,a-tDCS 并不能显著减少单个汉字中的拥挤现象。然而,a-tDCS 对字符间拥挤的影响还有待确定。
{"title":"Visual cortex anodal transcranial direct current stimulation does not alter reading performance for Chinese presented character-by-character to normal peripheral vision in older adults","authors":"Anqi Lyu, Andrew E. Silva, Benjamin Thompson, Larry Abel, A. M. Y. Cheong","doi":"10.3389/fnins.2024.1341307","DOIUrl":"https://doi.org/10.3389/fnins.2024.1341307","url":null,"abstract":"Visual cortex anodal transcranial direct current stimulation (a-tDCS) has been shown to reduce crowding in normal peripheral vision and may improve the reading of English words in patients with macular degeneration. Given the different visual requirements of reading English words and Chinese characters, the effect of a-tDCS on peripheral reading performance in English might differ from Chinese. This study recruited 20 participants (59–73 years of age) with normal vision and tested the hypothesis that a-tDCS would improve the reading of Chinese characters presented at 10° eccentricity compared with sham stimulation. Chinese sentences of different print sizes and exposure durations were presented one character at a time, 10° below or to the left of fixation. The individual critical print size (CPS) – the smallest print size eliciting the maximum reading speed (MRS) – was determined. Reading accuracies for characters presented 0.2 logMAR smaller than the individually fitted CPS were measured at four time points: before, during, 5 min after, and 30 min after receiving active or sham visual cortex a-tDCS. Participants completed both the active and sham sessions in a random order following a double-blind, within-subject design. No effect of active a-tDCS on reading accuracy was observed, implying that a single session of a-tDCS did not improve Chinese character reading in normal peripheral vision. This may suggest that a-tDCS does not significantly reduce the crowding elicited within a single Chinese character. However, the effect of a-tDCS on between-character crowding is yet to be determined.","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"56 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140659618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Neuroscience
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1